• 1
    Zur Hausen H. Papillomavirus infection—a major cause of human cancers. Biochim Biophys Acta. 1996; 1288: F55F78.
  • 2
    Zur Hausen H. Human papillomaviruses in the pathogenesis of human anogenital cancer. Virology. 1991; 184: 913.
  • 3
    Vousden KH, Doniger J, DiPaolo JA, Lowy DR. The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene. Oncogene Res. 1988; 3: 167175.
  • 4
    Barbosa MS, Schlegel R. The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transforming of human keratinocytes. Oncogene. 1989; 4: 15291532.
  • 5
    Watanabe S, Kanda T, Yoshiike K. Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7. J Virol. 1989; 63: 965969.
  • 6
    Beckman G, Birgander R, Sjalander A, et al. Is p53 polymorphism maintained by natural selection? Hum Hered. 1994; 44: 266270.
  • 7
    Storey A, Thomas M, Kalita A, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature (London). 1998; 393: 229234.
  • 8
    Yamashita T, Yaginuma Y, Saitoh Y, et al. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix. Carcinogenesis. 1999; 20: 17331736.
  • 9
    Szarka K, Veress G, Konya J, Gergely L. Frequency of p53 codon 72 genotypes in human papillomavirus associated squamous intraepithelial lesions and cervical cancer. Anticancer Res. 1999; 19: 23772379.
  • 10
    Ngan HYS, Liu VWS, Liu SS. Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53. Br J Cancer. 1999; 80: 18281829.
  • 11
    Minaguchi T, Kanamori Y, Matsushima M, Yoshikawa H, Taketanl Y, Nakamura Y. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res. 1998; 58: 45854586.
  • 12
    Kawaguchi H, Ohno S, Araki K, et al. p53 polymorphism in human papillomavirus-associated esophageal cancer. Cancer Res. 2000; 60: 27532755.
  • 13
    Peixoto GD, Hsin LS, Snijders P, et al. Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China. Cancer Lett. 2001; 162: 231235.
  • 14
    Li T, Lu ZM, Chen KN, et al. Human papillomavirus type 16 is an important infectious factor in the high incidence of esophageal cancer in Anyang area of China. Carcinogenesis. 2001; 22: 929934.
  • 15
    Guo M, Lu Z-M, Yao L-H, et al. HPV infection and its relationship with breast cancer with or without erbβ-2 gene over expression. Chinese Med J. [url:]
  • 16
    Lu ZM, Chen KN, Guo M, et al. Detection of HPV and EBV in human esophageal cancer in high-incident area and correlation with p53 expression. Chinese J Oncol. 2001; 23: 220223.
  • 17
    Levine A. p53, the cellular gatekeeper for growth and division. Cell. 1997; 88: 323331.
  • 18
    Hollstein M, Rice K, Greenblatt M, et al. Database of p53 gene somatic mutations in human tumours and cell lines. Nucleic Acids Res. 1994; 22: 35513555.
  • 19
    Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol. 1999; 19: 10921110.